Approvals/TGA/BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler

Approved

STANDARD

BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler

Grand Medical Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 5e9ff34c48cbdcd3
Company: Grand Medical Pty Ltd
Type: Standard

Approval Details

Approval Id: 5e9ff34c48cbdcd3
Product Name: BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler
Artg Id: 385649
Artg Name: BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler
Sponsor: Grand Medical Pty Ltd
Company Detail Path: /organization/grand-medical-pty-ltd
Artg Date: 2022-07-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

5e9ff34c48cbdcd3

Type

Standard

Back to TGA Approvals